Zelira Therapeutics (AU:ZLD) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Zelira Therapeutics has issued 3.5 million convertible notes valued at $1.4 million to replace a Convertible Loan Agreement. This change reflects a strategic financial move by the company to potentially strengthen its capital structure. Investors may find this development noteworthy as it could impact the company’s financial health and stock performance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
